Pfizer Inc
NYSE: PFE
$24.80
-$1.22 (-4.7%)
Closing Price on November 15, 2024
PFE Articles
The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
Published:
Last Updated:
Among the six most heavily shorted stocks traded on the New York Stock Exchange, short sellers continued to pile on Alcoa and Freeport-McMoRan between the January 15 and January 29 settlement dates.
Published:
Last Updated:
Merrill Lynch has decided to add Pfizer as its new top pick for 2016. The firm reiterated a Buy rating with a $39 price target.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday include Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce,com, Tesla and Yelp.
Published:
Last Updated:
If you ever want to look for value in a sector in the stock market, then when you see Congress calling in some of the top companies to scold them for political purposes, you may want to start buying.
Published:
Last Updated:
After Pfizer and Merck released their most recent earnings reports last week, analysts weighed in on both of these pharmaceutical giants.
Published:
Last Updated:
Needless to say, the stock market can be a very cruel mistress. So what are patient long-term investors to do?
Published:
Last Updated:
Pfizer reported better-than-expected fourth-quarter and full-year 2015 results before markets opened Tuesday morning.
Published:
Last Updated:
Pfizer is scheduled to report its fourth-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of the three Dow Jones Industrial Average companies that are reporting their quarterly results this week.
Published:
Last Updated:
Some of the Dow stocks that are down in 2016 haven't even reported earnings. This is the market bracing for bad news, but one cannot wonder if that means that the earnings bar is being lowered...
Published:
Last Updated:
Needless to say, the stock market can be a very cruel mistress. Companies can report great numbers, but if the guidance is light? Look out!
Published:
Last Updated:
The January 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
Perhaps not surprisingly, in early January, short interest was on the rise for most of the top six most heavily shorted stocks traded on the New York Stock Exchange.
Published:
Last Updated:
These stocks are not exciting, but neither are market sell-offs and big paper losses like we have seen in January.
Published:
Last Updated: